iShares Nasdaq US Biotechnology

ETF description

This ETF focuses on investing in U.S. biotechnology companies, which are involved in the research, development, and manufacturing of medical products and technologies. These firms work on innovative solutions such as new drugs, treatments, and medical devices that can improve health outcomes and contribute to advancements in healthcare. By tracking an index that includes a variety of biotechnology companies, this ETF allows investors to gain exposure to this dynamic sector of the economy.

Investors interested in this ETF may be those who believe in the potential for growth within the biotechnology industry, as it can be influenced by trends in healthcare, medical advancements, and technological innovations. This ETF may appeal to individuals looking to diversify their investment portfolios by including a sector that is often considered high‑growth, though it may also come with higher volatility and risk.

Issuer details

iShares ETFs are issued and managed by BlackRock, the world’s largest asset management company.

With 800+ products globally and over $2trn in assets (as at June 2024), iShares ETFs are a flexible, low‑cost way for investors to gain exposure to various market segments, including fixed income, emerging markets and broad‑based indexes.

Index details

The Nasdaq US Biotechnology index offers a concentrated measure of the performance of the U.S. biotechnology sector, capturing the innovation and growth potential of companies involved in genetic research, drug development, and advanced medical technologies. By focusing on this dynamic sector, the index provides investors with targeted exposure to firms that are driving the future of healthcare.